Remdesivir output up, but supply bottlenecks remain
×
The production of most sought after anti-viral drug, Remdesivir, has increased significantly but its availability continues to be a challenge in some States and private hospitals.
The production capacity of the remdesivir injection by seven domestic manufacturers has increased from 38 lakh vials per month to nearly 119 lakh vials, the Ministry of Chemicals and Fertilisers said on Monday.
Developed by US-based Gilead Sciences Inc, Remdesivir is being used to treat Covid-19 patients with oxygen saturation below 95 per cent and those with moderate to severe symptoms. Hyderabad-based Hetero Drugs is a major manufacturer of Remdisivir followed by Cipla, Zydus Cadila, Mylan Labs, Dr Reddy’s Labs, Syngene and Jubilant Ingrevia.
Haryana to purchase anti-COVID drug developed by DRDO ANI | Updated: May 17, 2021 22:09 IST
Chandigarh (Haryana) [India], May 17 (ANI): Haryana will purchase anti-COVID drug 2DG developed by DRDO for treatment of coroanvirus patients, state Health Minister Anil Vij said.
He said the drug helps in faster recovery of patients and reduces supplemental oxygen dependence. The state has seen surge in COVID-19 cases in the second wave of the pandemic. Haryana will purchase anti-Covid drug 2DG developed by DRDO for treatment of covid patients. Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan Today released the drug which helps in faster recovery of patients and reduces supplemental oxygen dependence , Vij said in a tweet.
BDA Expands Senior Team: Sanjay Singh Joins as Head of BDA India pr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr.com Daily Mail and Mail on Sunday newspapers.
Telangana Govt Doing Audit of Remdesivir Consumption in Private Hospitals to Prevent Misuse: KTR May 14, 2021, 10:32 IST
IT and Industries Minister KTR on Thursday evening went live on social media platform Twitter and interacted directly with Twitteratti.
“Let’s do an #AskKTR session exclusively on all COVID related issues & what Govt plans are to tackle the pandemic. Please send in your comments, questions & suggestions,” Tweeted the Minister.
During the session, wishes poured in for the Minister who had recently recovered from Covid19. Many concerned citizens also enquired about his present health status.
During the two hour long session, #AskKTR remained on top trends in India on Twitter.